Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2024 16:00 ET | Source: QSAM Biosciences Inc.

QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals

Austin, TX, Feb. 07, 2024 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM) (“QSAM or the “Company”) has signed a definitive Agreement and Plan of Merger (the “Agreement”) providing for the...
June 01, 2021 08:00 ET | Source: Telix Pharmaceuticals Limited

Telix to Present at the 2021 Jefferies Virtual Healthcare Conference

MELBOURNE, Australia and NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Chief Executive Officer, Dr. Christian...
October 29, 2019 19:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals and AusHealth to Partner on Novel Therapeutics for Lung, Ovarian Cancer

MELBOURNE, Australia and ADELAIDE, Australia, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) has today announced that Telix and AusHealth have entered into a collaboration...
June 03, 2019 08:54 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals to Present at Jefferies Healthcare Conference

MELBOURNE, Australia and NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
October 14, 2018 18:00 ET | Source: Telix Pharmaceuticals Limited

Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging

MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
October 14, 2018 18:00 ET | Source: Telix Pharmaceuticals Limited

Telix and ANMI Expand PSMA Imaging Partnership

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
June 17, 2018 20:06 ET | Source: Telix Pharmaceuticals Limited

Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing

MELBOURNE, Australia, June 18, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
November 14, 2017 20:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
November 08, 2017 18:20 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...
September 17, 2017 18:00 ET | Source: Telix Pharmaceuticals Limited

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...